Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Momenta Pharmaceuticals, Inc. is a biotechnology company specializing in the detailed structural analysis and design of complex sugars for the development of improved versions of existing drugs, the development of novel drugs and the discovery of new biological processes. Momenta is also utilizing its ability to sequence sugars to create technology-enabled generic versions of sugar-based and complex drug products. The Company’s most advanced product candidate is M-Enoxaparin, a technology-enabled generic version of Lovenox®. Based on its understanding of complex sugars, Momenta has created a diversified pipeline of near-term product opportunities, novel development products and discovery candidates. Momenta was founded in 2001 and is headquartered in Cambridge, ( www.momentapharma.com )
Momenta Pharmaceuticals , Inc.
675 West Kendall Street
Cambridge, Massachusetts 02142
USA
Tel: (617) 491-9700
Fax: (617) 621-0431